ProMetic's PBI-4050 Delivers New Positive Preclinical Results in Liver Fibrosis and Liver Cancer
Marketwire - Thu Apr 10, 6:01AM CDT
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporation"
ProMetic's PBI-4050 Shown to Reduce Blood Glucose and Kidney Fibrosis in Preclinical Models of Human Type II Diabetes and Kidney Disease
Marketwire - Thu Apr 03, 8:04AM CDT
ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF), ("ProMetic" or the "Corporation"
ProMetic Reports Successful Pre-IND Meeting with the FDA
Marketwire - Wed Apr 02, 6:02AM CDT
ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("ProMetic" or the "Corporation"
ProMetic Reports its 2013 Fourth Quarter and Financial Year End Results and Business Highlights
Marketwire Canada - Wed Mar 26, 4:11PM CDT
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX
ProMetic to Report its Fourth Quarter and Year End 2013 Financial Results and Hold Conference Call/Webcast
Marketwire - Fri Mar 21, 11:55AM CDT
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF) ("ProMetic" or the "Corporation"
ProMetic Receives $3.2 Million Via Loan Repayment
Marketwire - Tue Mar 11, 5:31AM CDT
ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF), ("ProMetic" or the "Corporation"
Avivagen Announces Nomination of New Director Mr. G.F. Kym Anthony Standing for Election
ACCESSWIRE - Fri Feb 28, 7:02AM CST
OTTAWA, ONTARIO / February 28, 2014 / ACCESSWIRE / Avivagen Inc. (TSXV:VIV), a wellness company developing and delivering products that support and enhance the health and quality of life for animals and the people who care for them, announces the nomination of a new Director, Mr. G.F. Kym Anthony, and the retirement of its current Chairman, Mr. Jacques Brault.
ProMetic Enters Into $1.6 Million Development Agreement With New Client
Marketwire - Thu Feb 06, 12:25PM CST
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporation"
ProMetic Announces the Appointment of its New Chief Medical Officer
Marketwire - Thu Feb 06, 5:31AM CST
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporation"
ProMetic Achieves Key Plasma Protein Manufacturing Milestone
Marketwire - Wed Jan 22, 6:01AM CST
ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporation"
Bioseparation Systems for Global Biopharmaceutical Markets: 2013 Report
M2 - Tue Dec 17, 5:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/8b887q/bioseparation) has announced the addition of the "Bioseparation Systems for Global Biopharmaceutical Markets: 2013 Report" report to their offering. Bioseparations systems can be categorized into three types: chromatography, membranes/filters and centrifuges. The demand for single use products is increasing and fueling growth of the global bioseparations market. New biosimilars are driving the increase in global biomanufacturing capacity. Blockbuster biologics are going off patent, leaving the market open for developing and manufacturing low cost biosimilars. This report provides market revenue size and growth rates for North America, Europe, Asia-Pacific (Japan, South Korea, Singapore) and the emerging BRICs (Brazil, Russia, India, China). Single-use products, manufacturing capacity, applications of bioseparations in downstream processing, downstream processing bottlenecks and emerging bioseparations technologies are covered in detail. The report also analyzes the competitive landscape, including key players' strengths and weaknesses, opportunities, gaps and industry trends. Detailed tables and charts with sales forecasts and marketshare data are also included. Scope of the Report - Single use products - Manufacturing capacity - Applications of bioseparations in downstream processing - Downstream processing bottlenecks - Emerging bioseparations technologies - Manufacturing capacity by biopharmaceutical company, CMO and region Key Topics Covered: 1. Introduction 2. Overview 3. Biologics in the Development Phase 4. Bioseparations Products and Systems 5. The Biopharmaceutical Manufacturing Process 6. Bioseparation Processes Used for Biologics Manufacturing 7. Global Bioseparation Market Analysis 8. The Global Bioseparations Market by Region 9. Competitive Landscape 10. Industry Analysis 11. Single-Use Bioseparations Systems and Products 12. Chromatography for Bioseparations 13. Filters and Membranes Used for Bioseparations 14. Industrial Centrifuges for Downstream Processing 15. Company Profiles Companies Mentioned: - Agilent Technologies - Alfa Wassermann Separation Technologies - Applied Biosystems Corporation (Life Technologies) - Asahi Kasei - Bio-Rad Laboratories - Carr Centritech - Celeros - DSM Biologics - Dow Chemical Company - Flottweg Separations Technology - G-Con Manufacturing - GE Healthcare Life Sciences - GEA Westfalia Separator Group - Hitachi Koki Co LTD - Knauer - Kronlab (YMC Europe) - Life Technologies - M Cuno - Meissner Filtration Products, Inc - Merck Millipore - Novasep Life Sciences Manufacturing Solutions - Novavax - NuSep Holdings Ltd - Pall Corporation - ProMetic Life Sciences Inc - Sartorius Stedim Biotech - SciLog - Spectrum Laboratories - Tarpon Biosystems - Tosoh Bioscience - US Filter Control Systems, Inc - Waters Corporation For more information visit http://www.researchandmarkets.com/research/8b...separation